Browsing Centre for Oral Immunobiology and Regenerative Medicine by Author "Gammon, L"
Now showing items 1-3 of 3
-
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.
Ali, L; Saxena, G; Jones, M; Leisegang, GR; Gammon, L; Gnanapavan, S; Giovannoni, G; Schmierer, K; Baker, D; Kang, AS (2020-02-25)Aim: The humanized anti-CD52 monoclonal antibody alemtuzumab depletes lymphocytes and is currently used to treat relapsing multiple sclerosis. During treatment, anti-alemtuzumab antibodies may develop and reduce effective ... -
Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris
Huang, Y; Jedličková, H; Cai, Y; Rehman, A; Gammon, L; Ahmad, US; Uttagomol, J; Parkinson, EK; Fortune, F; Wan, H (Frontiers Media, 2021-04-19) -
Oxidative stress-mediated yes-associated protein dysregulation contributes to the pathogenesis of pemphigus vulgaris
Huang, Y; Jedlickova, H; Cai, Y; Rehman, A; Gammon, L; Ahmad, US; Uttagomol, J; Chance, R; Kang, A; Parkinson, EK (Frontiers Media, 2022-04-19)Pemphigus Vulgaris (PV) is a life-threatening autoimmune disease manifested with blisters in the skin and mucosa and caused by autoantibodies against adhesion protein desmoglein-3 (Dsg3) expressed in epithelial membrane ...